Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tinzyme is a specialized biotechnology company focused on the research, development, and large-scale production of molecular biology enzymes and related reagents. The company serves as a critical raw material supplier for the in vitro diagnostics (IVD) industry, providing high-purity components for PCR, qPCR, and isothermal amplification assays. Their portfolio includes a wide range of DNA polymerases, reverse transcriptases, and NGS library preparation tools designed for high sensitivity and stability. Tinzyme utilizes proprietary enzyme engineering and protein purification platforms to meet the rigorous demands of clinical diagnostic applications. By offering both catalog products and customized bulk manufacturing, the company supports global diagnostic kit developers and life science researchers. The company is headquartered in Wuhan, China, and maintains a significant presence in the international life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tinzyme.